Logo MSM

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo MSM Logo MSM Logo MSM

04 May 2021: Editorial

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections

Dinah V. Parums *

DOI: 10.12659/MSM.932915

Med Sci Monit 2021; 27:e932915


ABSTRACT: There have been rapid developments in safe and effective mRNA vaccines for zoonotic infections in the past year. Years of research have made these advances possible, leading to in vitro-transcribed (IVT) mRNA expressing therapeutic proteins. There are several advantages of mRNA vaccines that include their low-cost manufacturing process, large-scale and rapid production, and the ability to modify the vaccines in response to emerging infections and viral variants. The COVID-19 pandemic and successful vaccination programs for SARS-CoV-2 have highlighted the advantages of mRNA vaccines. Also, mRNA vaccines are in development for several other potential pandemic zoonotic infections, including Ebola virus, rabies virus, Zika virus, HIV-1, and influenza. There may also be hope for the control of pandemic avian influenza by the combination of improved and rapid viral genotyping and the rapid development and mass production of mRNA vaccines. This Editorial aims to present a brief overview of how mRNA vaccines may help control and future epidemic, pandemic, and endemic zoonotic virus infections.

Keywords: Vaccines, COVID-19 vaccine, Influenza, Human, Zoonoses, epidemics, Pandemics, Editorial


New outbreaks from zoonotic viral infections, including from coronaviruses and influenza viruses, require early detection and control to prevent the development of future pandemic and endemic disease. Influenza virus variants and SARS-CoV-2 viral infections are now endemic. The hope lies in rapid and effective vaccination programs that include mRNA vaccine technology.


1. Karikó K: In vitro-transcribed mRNA therapeutics: Out of the shadows and into the spotlight: Mol Ther, 2019; 27(4); 691-92

2. Weissman D, Karikó K: mRNA: Fulfilling the promise of gene therapy: Mol Ther, 2015; 23; 1416-17

3. Maruggi G, Zhang C, Li J: mRNA as a transformative technology for vaccine development to control infectious diseases: Mol Ther, 2019; 27; 757-72

4. Pardi N, Hogan MJ, Pelc RS: Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination: Nature, 2017; 543(7644); 248-51

5. Dolgin E: How COVID unlocked the power of RNA vaccines: Nature, 2021; 589(7841); 189-91

6. Polack FP, Thomas SJ, Kitchin N: Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine: N Engl J Med, 2020; 383(27); 2603-15

7. Polack FP, Thomas SJ, Kitchin N:: Pfizer-BioNTech COVID-19 Vaccine, 2020

8. Baden LR, El Sahly HM, Essink B: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine: N Engl J Med, 2021; 384(5); 403-16

9. Baden LR, El Sahly HM, Essink B:: Emergency Use Authorization Factsheet. mRNA-1273 SARS-CoV-2 vaccine, 2020

10. Wang Y, Zhang Z, Luo J: mRNA vaccine: A potential therapeutic strategy: Mol Cancer, 2021; 20(1); 33

11. Molinari NA, Ortega-Sanchez IR, Messonnier ML: The annual impact of seasonal influenza in the US: Measuring disease burden and costs: Vaccine, 2007; 25(27); 5086-96

12. Molinari NA, Ortega-Sanchez IR, Messonnier ML:: Influenza (Seasonal)

13. Molinari NA, Ortega-Sanchez IR, Messonnier ML:: Influenza (Flu). Past pandemics

14. Lazarus R, Lim PL: Avian influenza: Recent epidemiology, travel-related risk, and management: Curr Infect Dis Rep, 2015; 17(1); 456

15. Feldman RA, Fuhr R, Smolenov I: mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials: Vaccine, 2019; 37(25); 3326-34

16. Bailey ES, Fieldhouse JK, Choi JY, Gray GC: A mini review of the zoonotic threat potential of influenza viruses, coronaviruses, adenoviruses, and enteroviruses: Front Public Health, 2018; 6; 104

17. Mascola JR, Fauci AS: Novel vaccine technologies for the 21 century: Nat Rev Immunol, 2020; 20(2); 87-88

Coronavirus/Covid 19

08 September 2021 : Clinical Research

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

Med Sci Monit In Press; DOI: 10.12659/MSM.932788  

16 July 2021 : Review article

Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.930776  

09 July 2021 : Database Analysis

A Simple Clinical Prediction Tool for COVID-19 in Primary Care with Epidemiology: Temperature-Leukocytes-CT...

Med Sci Monit In Press; DOI: 10.12659/MSM.931467  

In Press

20 Sep 2021 : Clinical Research

Comparison of the Use of Magnetic Resonance Imaging of Partial Anterior Cruciate Ligament Tears Using Maxim...

Med Sci Monit In Press; DOI: 10.12659/MSM.932228  

20 Sep 2021 : Clinical Research

Automated Boluses and Delayed-Start Timers Prolong Perineural Local Anesthetic Infusions and Analgesia Foll...

Med Sci Monit In Press; DOI: 10.12659/MSM.933190  

16 Sep 2021 : Clinical Research

A Retrospective Evaluation of Operative and Postoperative Outcomes in Patients with Spinal Metastases from ...

Med Sci Monit In Press; DOI: 10.12659/MSM.932995  

15 Sep 2021 : Clinical Research

Polish Medical Air Rescue Interventions Concerning Pregnant Women in Poland: A 10-year Retrospective Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.933029  

Most Viewed

20 Mar 2020 : Clinical Research

Social Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...

DOI :10.12659/MSM.923921

Med Sci Monit 2020; 26:e923921

15 Apr 2020 : Clinical Research

Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...

DOI :10.12659/MSM.924171

Med Sci Monit 2020; 26:e924171

05 May 2020 : Review article

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development

DOI :10.12659/MSM.924700

Med Sci Monit 2020; 26:e924700

26 Apr 2020 : Clinical Research

Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus P...

DOI :10.12659/MSM.924609

Med Sci Monit 2020; 26:e924609

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750